Target intelligence / Profile preview

Heme detoxification process (HDP)

Target
HDP
Molecular classification
Metabolic pathway, Biocrystallization process
01

Overview

The heme detoxification process is a vital metabolic pathway in Plasmodium parasites, particularly Plasmodium falciparum, occurring within the acidic digestive vacuole during the intraerythrocytic stage of infection (Coronado et al., 2014, NIH). As the parasite digests host hemoglobin to obtain essential amino acids, it releases large quantities of free heme (ferriprotoporphyrin IX), which is highly toxic due to its capacity to generate reactive oxygen species and disrupt cellular membranes (Hempelmann, 2007, PubMed). To mitigate this toxicity, the parasite converts free heme into an inert, insoluble crystalline polymer known as hemozoin, or malaria pigment. This biocrystallization is facilitated by the Heme Detoxification Protein (HDP) and occurs within the lipid environment of the vacuole (Jani et al., 2008, PLoS Pathogens). This pathway is the primary target for several classes of antimalarial drugs, including 4-aminoquinolines like chloroquine and quinoline alcohols like quinine. These drugs interfere with the formation of hemozoin, leading to the accumulation of toxic heme and subsequent parasite death (StatPearls, 2023). Despite the rise of drug resistance mediated by transporters like PfCRT, this process remains a critical focus for antimalarial drug discovery.

Other names
Hemozoin formationHeme biocrystallizationHemoglobin degradation pathwayFerriprotoporphyrin IX detoxification
02

Mechanism of action

Inhibition of heme biocrystallization into hemozoin, leading to the accumulation of toxic ferriprotoporphyrin IX (heme) which causes oxidative damage and parasite lysis (StatPearls, 2023).

03

Biological functions

DetoxificationIron metabolismHemoglobin catabolismHomeostasis
04

Disease associations

MalariaInfection
05

Safety considerations

Drug resistanceCardiotoxicity (QT prolongation)NeurotoxicityRetinopathy
06

Interacting drugs

Chloroquine

7 more in the full profile.

07

Biomarkers

Hemozoin levelsParasitemiaPfCRT (Plasmodium falciparum chloroquine resistance transporter) mutations

Beyond the preview

Go deeper on Heme detoxification process (HDP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heme detoxification process (HDP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call